Last reviewed · How we verify

NCT04358042: PSYCHIC

PSYCHIATRIC Disorders and Covid-19

Terminated Last updated 5 October 2021
What this trial tests

trial testing Brief Psychiatric Rating Scale in Psychiatric Disorder in 20 participants. Terminated before completion.

Timeline
24 April 2020
Primary endpoint
2 July 2020
2 July 2020

Quick facts

Lead sponsorNantes University Hospital
StatusTerminated
Study typeOBSERVATIONAL
Enrollment20
Start date24 April 2020
Primary completion2 July 2020
Estimated completion2 July 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Nantes University Hospital

Who can join

15 and older, any sex, with Psychiatric Disorder or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Given the possible risks and complications of a comorbidity between psychiatric disorder and coronavirus disease 2019 (COVID-19), it seems particularly important to specify the impact of the COVID-19 pandemic in patients with psychiatric disorders and suspected of infection, hospitalized in a specific unit, at the psychiatric, somatic and pharmacological level.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. SARS-Cov-2 Damage on the Nervous System and Mental Health.
    Boulkrane MS, Ilina V, Melchakov R, Arisov M, et al · · 2022 · cited 4× · PMID 34191699 · DOI 10.2174/1570159x19666210629151303

Verify or expand the search:

Other recruiting trials for Psychiatric Disorder

Currently open trials in the same condition.

Other Nantes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04358042.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing